Correlation Between HTG Molecular and BioAffinity Technologies,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HTG Molecular and BioAffinity Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HTG Molecular and BioAffinity Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HTG Molecular Diagnostics and bioAffinity Technologies,, you can compare the effects of market volatilities on HTG Molecular and BioAffinity Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HTG Molecular with a short position of BioAffinity Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of HTG Molecular and BioAffinity Technologies,.

Diversification Opportunities for HTG Molecular and BioAffinity Technologies,

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between HTG and BioAffinity is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding HTG Molecular Diagnostics and bioAffinity Technologies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on bioAffinity Technologies, and HTG Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HTG Molecular Diagnostics are associated (or correlated) with BioAffinity Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of bioAffinity Technologies, has no effect on the direction of HTG Molecular i.e., HTG Molecular and BioAffinity Technologies, go up and down completely randomly.

Pair Corralation between HTG Molecular and BioAffinity Technologies,

Given the investment horizon of 90 days HTG Molecular Diagnostics is expected to generate 2.35 times more return on investment than BioAffinity Technologies,. However, HTG Molecular is 2.35 times more volatile than bioAffinity Technologies,. It trades about 0.01 of its potential returns per unit of risk. bioAffinity Technologies, is currently generating about 0.02 per unit of risk. If you would invest  298.00  in HTG Molecular Diagnostics on August 29, 2024 and sell it today you would lose (241.00) from holding HTG Molecular Diagnostics or give up 80.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy31.45%
ValuesDaily Returns

HTG Molecular Diagnostics  vs.  bioAffinity Technologies,

 Performance 
       Timeline  
HTG Molecular Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HTG Molecular Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, HTG Molecular is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
bioAffinity Technologies, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days bioAffinity Technologies, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

HTG Molecular and BioAffinity Technologies, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HTG Molecular and BioAffinity Technologies,

The main advantage of trading using opposite HTG Molecular and BioAffinity Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HTG Molecular position performs unexpectedly, BioAffinity Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies, will offset losses from the drop in BioAffinity Technologies,'s long position.
The idea behind HTG Molecular Diagnostics and bioAffinity Technologies, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios